Status:
UNKNOWN
Attenuation of Tonal Tinnitus by Lateral Inhibition Therapy
Lead Sponsor:
Ramsay Générale de Santé
Collaborating Sponsors:
Dr Quemar
Conditions:
Tinnitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Lateral Inhibition Therapy (TIL) corrects the patient's hearing by notched amplification on the patient's listening soundtrack. This half-octave notch is targeted at tinnitus frequencies measured tona...
Detailed Description
In France, up to 16 million people suffer from tinnitus or ringing in the ears daily. This parasitic sound that does not come from the patient's environment can interfere with each individual in a var...
Eligibility Criteria
Inclusion
- Patient over 18 years old.
- Patient with disabling tonal tinnitus (THI score\> 40) for more than 6 months.
- Patient with a hearing loss of at least 25dB, centered on the frequency of tinnitus and requiring hearing aids
- Patient who has never used a hearing aid or a tinnitus masking system.
- Patient who stopped all tinnitus treatment at least 1 month before the start of the study (drug treatment, psychotherapy).
- Patient being willing to attend all of the visits planned as part of the study.
- Patient affiliated or beneficiary of a social security scheme.
- Patient having signed the free and informed consent
Exclusion
- Minor patient.
- Patient with hyperacusis
- Patient already with a hearing aid or tinnitus masker.
- Patient undergoing psychotropic or neurotropic drug treatments.
- Patient with a history of psychological or psychiatric disorders.
- Patient with a contraindication to wearing hearing aids.
- Patient suffering from non-disabling tinnitus (THI score \<40).
- Patient suffering from intermittent, non-tonal or pulsatile tinnitus.
- Patient participating in another clinical study.
- Protected patients: adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision.
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
July 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04807686
Start Date
July 19 2019
End Date
December 31 2021
Last Update
March 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé Clairval
Marseille, France, 13009